Probiotics (living agents) & Metabolic Syndrome (MetS)

Considered are

• Akkermansia muciniphila & Metabolic Syndrome (MetS)


• Akkermansia muciniphila inactivated & Metabolic syndrome (MetS)

No published were found as of March 2026

• Anaerobutyricum soehngenii & Metabolic Syndrome (MetS)


• Bifidobacterium pseudocatenulatum & Metabolic syndrome (MetS)

Bifidobacterium pseudocatenulatum CECT 7765, in conjunction with dietary recommendations, has beneficial effects on inflammatory markers and lipid profiles. This indicates that it can enhance the inflammatory status in children facing obesity and insulin resistance. These positive outcomes are accompanied by increases in bacterial groups associated with a lean phenotype. Consequently, employing probiotic supplementation to modulate gut microbiota can be considered an effective approach to mitigating certain obesity-related disorders in children
Sanchis-Chordà et al. 2019 Eur J Nutr. 58: 2789–2800

• Lacticaseibacillus casei & Metabolic syndrome (MetS)


• Limosilactobacillus reuteri & Metabolic syndrome (MetS)


• Yogurt & Non-alcoholic fatty liver disease (NAFLD) + Metabolic Syndrome (MetS)

Probiotics intake may alleviate some of the clinical components of metabolic diseases
Gawlik-Kotelnicka & Strzelecki 2021 Pharmaceuticals 14: 384

Lacticaseibacillus casei LC2W can help prevent Metabolic Syndrome (MetS) by improving clinical outcomes and modulating microflora.
Wang et al. 2025 Probiotics Antimicrob Proteins 17(6): 3811-3825

The results of the majority of the studies revealed that probiotics have some significant effects on cholesterol levels. It has shown a reduction in triglycerides and Low-Density Lipoprotein Cholesterol (LDL-C) thereby decreasing cholesterol levels in the blood. However, further investigations must be carried out so in order to create a more detailed and specific explanation of the effects and mechanisms of probiotics on maintaining cholesterol levels in the blood.
Momin et al. 2023 Cureus 15(4): e37567

Akkermansia muciniphila improves several metabolic parameters. Pasteurization (70°C for 30 min) exposes beneficial outer membrane proteins without viability issues, potentially explaining enhanced efficacy in metabolic parameters.
Depommier et al. 2019 Nat Med. 25(7): 1096-1103

Limosilactobacillus reuteri V3401 did not show any efficacy regarding the primary outcome measures
Tenorio-Jiménez et al. 2019 Nutrients 11: 1761

see also:
Lactobacillus spp & Metabolic Syndrome (MetS)
Metabolic Syndrome (MetS) & Drugs/Treatments
Mode of Action (MoA) & Probiotics (living agents)
Nutritional Therapy & Metabolic Syndrome (MetS)
Yogurt & Metabolic Syndrome (MetS)
Probiotics (living agents) & Hypercholesterolemia (HChol)